These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 24037726)

  • 21. Macrocytosis, macrocytic anemia, and genetic polymorphisms of alcohol dehydrogenase-1B and aldehyde dehydrogenase-2 in Japanese alcoholic men.
    Yokoyama A; Yokoyama T; Brooks PJ; Mizukami T; Matsui T; Kimura M; Matsushita S; Higuchi S; Maruyama K
    Alcohol Clin Exp Res; 2014 May; 38(5):1237-46. PubMed ID: 24588059
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell-Cycle-Specific Function of p53 in Fanconi Anemia Hematopoietic Stem and Progenitor Cell Proliferation.
    Li X; Wilson AF; Du W; Pang Q
    Stem Cell Reports; 2018 Feb; 10(2):339-346. PubMed ID: 29307578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic disruption of both Fancc and Fancg in mice recapitulates the hematopoietic manifestations of Fanconi anemia.
    Pulliam-Leath AC; Ciccone SL; Nalepa G; Li X; Si Y; Miravalle L; Smith D; Yuan J; Li J; Anur P; Orazi A; Vance GH; Yang FC; Hanenberg H; Bagby GC; Clapp DW
    Blood; 2010 Oct; 116(16):2915-20. PubMed ID: 20606166
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fancd2 counteracts the toxic effects of naturally produced aldehydes in mice.
    Langevin F; Crossan GP; Rosado IV; Arends MJ; Patel KJ
    Nature; 2011 Jul; 475(7354):53-8. PubMed ID: 21734703
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The maternal side of Fanconi Anemia.
    Ruiz S; Fernandez-Capetillo O
    Mol Cell; 2014 Sep; 55(6):803-804. PubMed ID: 25238193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of complementation group and mutation type with clinical outcome in fanconi anemia. European Fanconi Anemia Research Group.
    Faivre L; Guardiola P; Lewis C; Dokal I; Ebell W; Zatterale A; Altay C; Poole J; Stones D; Kwee ML; van Weel-Sipman M; Havenga C; Morgan N; de Winter J; Digweed M; Savoia A; Pronk J; de Ravel T; Jansen S; Joenje H; Gluckman E; Mathew CG
    Blood; 2000 Dec; 96(13):4064-70. PubMed ID: 11110674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In Fanconi anemia, impaired accumulation of bone marrow neutrophils during emergency granulopoiesis induces hematopoietic stem cell stress.
    Hu L; Huang W; Liu B; Eklund EA
    J Biol Chem; 2024 Aug; 300(8):107548. PubMed ID: 38992437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence for complete epistasis of null mutations in murine Fanconi anemia genes Fanca and Fancg.
    van de Vrugt HJ; Koomen M; Bakker S; Berns MA; Cheng NC; van der Valk MA; de Vries Y; Rooimans MA; Oostra AB; Hoatlin ME; Te Riele H; Joenje H; Arwert F
    DNA Repair (Amst); 2011 Dec; 10(12):1252-61. PubMed ID: 22036606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fanconi anemia core complex gene promoters harbor conserved transcription regulatory elements.
    Meier D; Schindler D
    PLoS One; 2011; 6(8):e22911. PubMed ID: 21826217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical, cytogenetic and molecular findings in nine Moroccan patients with Fanconi anemia.
    Doubaj Y; Zrhidri A; Elalaoui SC; Lyahyai J; El Kadiri Y; Elkassimi N; Sbiti A; El Kababri M; Hessissen L; Sefiani A
    Pan Afr Med J; 2021; 39():72. PubMed ID: 34422195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ALDH2 mutations and defense against genotoxic aldehydes in cancer and inherited bone marrow failure syndromes.
    Woo AY; Jia L
    Mutat Res; 2024; 829():111870. PubMed ID: 38944932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pluripotent cell models of fanconi anemia identify the early pathological defect in human hemoangiogenic progenitors.
    Suzuki NM; Niwa A; Yabe M; Hira A; Okada C; Amano N; Watanabe A; Watanabe K; Heike T; Takata M; Nakahata T; Saito MK
    Stem Cells Transl Med; 2015 Apr; 4(4):333-8. PubMed ID: 25762002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bone Marrow Mesenchymal Stem Cells Carrying FANCD2 Mutation Differ from the Other Fanconi Anemia Complementation Groups in Terms of TGF-β1 Production.
    Cagnan I; Gunel-Ozcan A; Aerts-Kaya F; Ameziane N; Kuskonmaz B; Dorsman J; Gumruk F; Uckan D
    Stem Cell Rev Rep; 2018 Jun; 14(3):425-437. PubMed ID: 29247345
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heterogeneous activation of the Fanconi anemia pathway by patient-derived FANCA mutants.
    Adachi D; Oda T; Yagasaki H; Nakasato K; Taniguchi T; D'Andrea AD; Asano S; Yamashita T
    Hum Mol Genet; 2002 Dec; 11(25):3125-34. PubMed ID: 12444097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hematological consequences of a FANCG founder mutation in Black South African patients with Fanconi anemia.
    Feben C; Kromberg J; Wainwright R; Stones D; Poole J; Haw T; Krause A
    Blood Cells Mol Dis; 2015 Mar; 54(3):270-4. PubMed ID: 25477267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct interaction of the Fanconi anaemia protein FANCG with BRCA2/FANCD1.
    Hussain S; Witt E; Huber PA; Medhurst AL; Ashworth A; Mathew CG
    Hum Mol Genet; 2003 Oct; 12(19):2503-10. PubMed ID: 12915460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization and genotype-phenotype correlation of patients with Fanconi anemia in a multi-ethnic population.
    Steinberg-Shemer O; Goldberg TA; Yacobovich J; Levin C; Koren A; Revel-Vilk S; Ben-Ami T; Kuperman AA; Zemer VS; Toren A; Kapelushnik J; Ben-Barak A; Miskin H; Krasnov T; Noy-Lotan S; Dgany O; Tamary H
    Haematologica; 2020 Jul; 105(7):1825-1834. PubMed ID: 31558676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for subcomplexes in the Fanconi anemia pathway.
    Medhurst AL; Laghmani el H; Steltenpool J; Ferrer M; Fontaine C; de Groot J; Rooimans MA; Scheper RJ; Meetei AR; Wang W; Joenje H; de Winter JP
    Blood; 2006 Sep; 108(6):2072-80. PubMed ID: 16720839
    [TBL] [Abstract][Full Text] [Related]  

  • 39. p53-TP53-Induced Glycolysis Regulator Mediated Glycolytic Suppression Attenuates DNA Damage and Genomic Instability in Fanconi Anemia Hematopoietic Stem Cells.
    Li X; Wu L; Zopp M; Kopelov S; Du W
    Stem Cells; 2019 Jul; 37(7):937-947. PubMed ID: 30977208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Aldehyde degradation deficiency (ADD) syndrome: discovery of a novel fanconi anemia-like inherited BMF syndrome due to combined ADH5/ALDH2 deficiency].
    Mu A; Hira A; Matsuo K; Takata M
    Rinsho Ketsueki; 2021; 62(6):547-553. PubMed ID: 34219079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.